Shares of Inari Medical catapulted to a 12-month high Monday on a report medical devices maker Stryker is in advanced talks to buy it.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker is now opening its pocketbook a bit wider to acquire Inari Medical with its portfolio of blood-clot-busting devices and 1,400 employees. Stryker will put down $80 per share in cash for ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

Inari’s portfolio of medical devices and accessories to treat venous thromboembolism (VTE), or blood clots in the veins, was highly attractive to Stryker, according to Inari Chief Executive Drew Hykes ...

Investing.com -- Inari Medical Inc (NASDAQ ... a condition where blood clots form in veins, as well as other vascular diseases. Stryker will pay $80 per share for Inari, as initially reported ...

NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical ... where a blood clot forms in a vein, and other vascular diseases.

As such, it's worth looking deeper into each top mid-cap performer. Inari Medical Inc (NASDAQ:NARI) makes medical devices to treat blot clots in veins and their main products are designed to remove ...

Inari Medical (NASDAQ:NARI) makes medical devices. These devices are mostly used to treat blot clots in veins. Inari Medical is what I discussed before in an article talking about mid-cap stocks.